Achievement of international normalized ratio therapeutic range among chronic non-valvular atrial fibrillation patients treated with warfarin

被引：0
|
作者：
Harley, CR
Shetty, S
Hauch, O
Wygant, G
Riedel, AA
Nelson, M
机构：
[1] Ingenix, Eden Prairie, MN USA
[2] AstraZeneca LP, Wilmington, DE USA
来源：
CIRCULATION | 2004年 / 109卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P204
引用
收藏
页码：E271 / E271
页数：1
相关论文
共 50 条
  • [1] Optimal international normalized ratio in warfarin therapy in Korean patients with non-valvular atrial fibrillation
    Bae, M. H.
    Kim, J. H.
    Jang, S. Y.
    Park, S. H.
    Choi, W. S.
    Lee, J. H.
    Yang, D. H.
    Park, H. S.
    Cho, Y.
    Chae, S. C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1103 - 1103
  • [2] Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Wang, Li
    Baser, Onur
    Damaraju, C. V.
    Schein, Jeffrey R.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (05) : 333 - 340
  • [3] Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range
    Wankowicz, Pawel
    Nowacki, Przemyslaw
    Golab-Janowska, Monika
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (05) : 1217 - 1222
  • [4] Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation
    Yasaka, M
    Minematsu, K
    Yamaguchi, T
    INTERNAL MEDICINE, 2001, 40 (12) : 1183 - 1188
  • [5] Relationship between platelet indices and international normalized ratio in patients with non-valvular atrial fibrillation
    Arik, Osman Ziya
    Ozkan, Bugra
    Kutlu, Rasim
    Karal, Huseyin
    Sahin, Durmus Yildiray
    Kaypakli, Onur
    Ozel, Deniz
    Cayil, Murat
    PLATELETS, 2014, 25 (05) : 311 - 316
  • [6] Relationship Between Platelet Indices and International Normalized Ratio In Patients With Non-Valvular Atrial Fibrillation
    Arik, Osman Ziya
    Ozkan, Bugra
    Kutlu, Rasim
    Karal, Huseyin
    Memetoglu, Mehmet Erdem
    Sahin, Durmus Yildiray
    Tekin, Kamuran
    Kaypakli, Onur
    Ucak, Haci Ali
    Cayli, Murat
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C142 - C143
  • [7] Key Factors That Lower Time in Therapeutic Range of Warfarin in Patients with Non-Valvular Atrial Fibrillation
    Tanaka, T.
    Ihara, M.
    Yamagami, H.
    Toyoda, K.
    Nagatsuka, K.
    CEREBROVASCULAR DISEASES, 2015, 40 : 70 - 70
  • [8] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [9] Association of Out-of-Range International Normalized Ratio (INR) Values and Adverse Clinical Outcomes Among Newly Initiated Warfarin Patients With Non-Valvular Atrial Fibrillation and Comorbid Diabetes
    Nelson, Winnie W.
    Wang, Li
    Baser, Onur
    Damaraju, C. V.
    Schein, Jeffrey R.
    CIRCULATION, 2014, 130
  • [10] Warfarin utilization and stroke risk in patients with chronic non-valvular atrial fibrillation
    Boccuzzi, SJ
    Stephenson, JJ
    Kreilick, CA
    Beaulieu, JF
    Hauch, O
    Kim, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 335A - 335A
12345